` STXS (Stereotaxis Inc) vs S&P 500 Comparison - Alpha Spread

S
STXS
vs
S&P 500

Over the past 12 months, STXS has underperformed S&P 500, delivering a return of +12% compared to the S&P 500's +38% growth.

Stocks Performance
STXS vs S&P 500

Loading
STXS
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
STXS vs S&P 500

Loading
STXS
S&P 500
Difference
www.alphaspread.com

Performance By Year
STXS vs S&P 500

Loading
STXS
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Stereotaxis Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Stereotaxis Inc
Glance View

Market Cap
197.4m USD
Industry
Health Care

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.

STXS Intrinsic Value
1.33 USD
Overvaluation 34%
Intrinsic Value
Price $2.03
S
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett